Sign in
4

Changes in Ownership

NewAmsterdam Pharma Co N.V. Filed Acc 0001193125-26-009272

Chief Executive Officer sold 11,582 shares

  • Chief Executive Officer acquired 81,000 shares (grant or award)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Davidson Michael H. · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Owned after D/I
2026-01-07 Sale : show line 1 in the form 10b5-1 −11,582 378,859 D
2026-01-07 Grant or award : show line 2 in the form 10b5-1 +81,000 459,859 D
Open-market sales · 11,582 sh

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-01-07 Grant or award : show line 3 in the form 10b5-1 Option (right to buy) +364,000 364,000 D
Loading xslF345X05/ownership.xml…